The aim of this study is to examine the validity and reliability of the Turkish version of the Heat Sensitivity Scale in individuals with Parkinson's disease. This cross-sectional methodological study will evaluate the psychometric properties of the scale, including internal consistency, test-retest reliability, and construct validity, in order to provide a valid and reliable tool for assessing temperature sensitivity in Turkish-speaking individuals with Parkinson's disease.
Eligibility
Sex
ALL
Min age
40 Years
Max age
85 Years
Healthy volunteers
No
Inclusion Criteria:
* Clinical diagnosis of Parkinson's disease
* Hoehn and Yahr stage 1-3
* Age between 40 and 85 years
* Mini-Mental State Examination score ≥ 24
* Sufficient cognitive and communication ability to complete the assessments
* Attendance at the Movement Disorders Outpatient Clinic of the Neurology Department
* Willingness to participate and provide written informed consent
Exclusion Criteria:
* Presence of a major psychiatric disorder, such as major depressive disorder or a psychotic disorder
* Diagnosis of advanced dementia
* Presence of an uncontrolled systemic chronic disease, such as uncontrolled diabetes mellitus or hypertension
* Presence of a severe cardiovascular or respiratory condition
* Presence of an additional orthopedic or neurological condition that may affect assessment performance
* Severe visual or hearing impairment that may interfere with the assessments
* Inability to cooperate adequately during the assessments
Primary outcome measure(s)
Heat Sensitivity Scale Total Score — Baseline (at the time of questionnaire administration) Heat sensitivity will be assessed using the Turkish version of the Heat Sensitivity Scale in individuals with Parkinson's disease. The scale evaluates symptoms related to heat sensitivity and their impact on daily life. The total score ranges from 29 to 116, with higher scores indicating greater heat sensitivity-related problems and therefore a worse outcome. Psychometric properties, including internal consistency, test-retest reliability, and construct validity, will be analyzed.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.